[go: up one dir, main page]

DK1274718T3 - En fremgangsmåde til forberedelse af 7.alpha.-hydroxy 3-aminosubstituerede steroler vee en ubeskyttet 7.alpha.-hydroxy gruppe - Google Patents

En fremgangsmåde til forberedelse af 7.alpha.-hydroxy 3-aminosubstituerede steroler vee en ubeskyttet 7.alpha.-hydroxy gruppe

Info

Publication number
DK1274718T3
DK1274718T3 DK01926924T DK01926924T DK1274718T3 DK 1274718 T3 DK1274718 T3 DK 1274718T3 DK 01926924 T DK01926924 T DK 01926924T DK 01926924 T DK01926924 T DK 01926924T DK 1274718 T3 DK1274718 T3 DK 1274718T3
Authority
DK
Denmark
Prior art keywords
7alpha
hydroxy
vee
unprotected
amino
Prior art date
Application number
DK01926924T
Other languages
Danish (da)
English (en)
Inventor
William A Kinney
Xuehai Zhang
Ronald Michalak
Original Assignee
Genaera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaera Corp filed Critical Genaera Corp
Application granted granted Critical
Publication of DK1274718T3 publication Critical patent/DK1274718T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK01926924T 2000-04-12 2001-04-12 En fremgangsmåde til forberedelse af 7.alpha.-hydroxy 3-aminosubstituerede steroler vee en ubeskyttet 7.alpha.-hydroxy gruppe DK1274718T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19664600P 2000-04-12 2000-04-12
PCT/US2001/012004 WO2001079255A1 (fr) 2000-04-12 2001-04-12 Procede de preparation de 7.alpha.-hydroxy 3-aminosubstitues sterols au moyen de produits intermediaires dotes d'un groupe 7.alpha.-hydroxy non protege

Publications (1)

Publication Number Publication Date
DK1274718T3 true DK1274718T3 (da) 2007-02-12

Family

ID=22726246

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01926924T DK1274718T3 (da) 2000-04-12 2001-04-12 En fremgangsmåde til forberedelse af 7.alpha.-hydroxy 3-aminosubstituerede steroler vee en ubeskyttet 7.alpha.-hydroxy gruppe

Country Status (12)

Country Link
US (2) US6933383B2 (fr)
EP (1) EP1274718B1 (fr)
JP (1) JP2003531148A (fr)
AT (1) ATE342912T1 (fr)
AU (2) AU2001253427B2 (fr)
CA (1) CA2406847C (fr)
CY (1) CY1105870T1 (fr)
DE (1) DE60123939T2 (fr)
DK (1) DK1274718T3 (fr)
ES (1) ES2273831T3 (fr)
PT (1) PT1274718E (fr)
WO (1) WO2001079255A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410959B1 (en) * 2000-07-13 2008-08-12 Genaera Corporation Therapeutic uses for aminosterol compounds
EP1743902A4 (fr) * 2004-03-31 2009-04-01 Kuraray Co Procédé de fabrication d'un dérivé de 5alpha-pregnane
JPWO2005095432A1 (ja) * 2004-03-31 2008-02-21 株式会社クラレ ５α−プレグナン誘導体の製造方法
CN100509838C (zh) * 2004-03-31 2009-07-08 可乐丽股份有限公司 制备5α-孕烷衍生物的方法
JP2008504292A (ja) 2004-06-24 2008-02-14 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド 免疫増強用の化合物
US20070203106A1 (en) * 2005-03-31 2007-08-30 Kuraray Co., Ltd. Method for Producing 5Alpha-Pregnane Derivative
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
TW200808739A (en) 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
CA2922021C (fr) * 2007-09-06 2018-01-09 Ohr Pharmaceutical, Inc. Procede de traitement du diabete
EP2240475B1 (fr) 2007-12-20 2013-09-25 Novartis AG Dérivés de thiazole utilisés comme inhibiteur de la pi 3 kinase
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
US20110161139A1 (en) * 2009-12-31 2011-06-30 Accenture Global Services Gmbh Capability Accelerator
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
MX343706B (es) 2011-01-31 2016-11-18 Novartis Ag Derivados heterocíclicos novedosos.
AP2014007601A0 (en) 2011-10-28 2014-04-30 Novartis Ag Novel purine derivatives and their use in the treatment of disease
US10213432B2 (en) 2012-05-16 2019-02-26 Novartis Ag Dosage regimen for a PI-3 kinase inhibitor
JP2016539149A (ja) 2013-12-06 2016-12-15 ノバルティス アーゲー アルファ−アイソフォーム選択的ホスファチジルイノシトール３−キナーゼ阻害剤の投薬レジメン
WO2017077445A1 (fr) 2015-11-02 2017-05-11 Novartis Ag Schéma posologique pour un inhibiteur de la phosphatidylinositol 3-kinase
WO2018060833A1 (fr) 2016-09-27 2018-04-05 Novartis Ag Schéma posologique pour l'alpelisib, un inhibiteur de la phosphatidylinositol 3-kinase spécifique de l'isoforme alpha
CN109651475B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种制备16a-羟基泼尼松龙的新方法
CN109734764B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种17a-脱羟醋酸泼尼松龙的制备方法
CN109734765B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种17a-脱羟醋酸泼尼松龙产品的制备方法
CN109575096B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种制备16a-羟基泼尼松龙产品的新方法
CN113621016B (zh) * 2021-09-06 2022-05-17 北京泛球生物科技有限公司 一种地屈孕酮关键中间体的合成方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016390A (en) * 1960-06-30 1962-01-09 Searle & Co N-(substituted alkyl) amino-5alpha-androstan-17beta-ols
US3370070A (en) * 1965-06-16 1968-02-20 Searle & Co [n-alkyl-17-(dialkylaminoalkyl)amino] androst-4-en-3-ones
GB1565351A (en) 1975-06-02 1980-04-16 Theramex Steroid aminoethers
US4220598A (en) * 1977-11-14 1980-09-02 Abbott Laboratories Method and reagents for measuring the level of conjugated bile acids
US4550163A (en) * 1979-02-05 1985-10-29 Abbott Laboratories Ligand analog-irreversible enzyme inhibitor conjugates
US4301246A (en) * 1979-04-12 1981-11-17 Hoffmann-La Roche Inc. Process for chenodeoxycholic acid production
US4230625A (en) * 1979-04-12 1980-10-28 Hoffmann-La Roche Inc. Process for chenodeoxycholic acid and intermediates therefore
US4372888A (en) * 1980-08-26 1983-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Nondenaturing zwitterionic detergents
JPS5842878B2 (ja) * 1981-12-02 1983-09-22 名糖産業株式会社 １２−オキソコラン酸トシルヒドラゾン化合物、その製法ならびに利用
DE3366932D1 (en) * 1982-07-29 1986-11-20 Lehner Ag New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same
US5001116A (en) * 1982-12-20 1991-03-19 The Children's Medical Center Corporation Inhibition of angiogenesis
US4994443A (en) * 1982-12-20 1991-02-19 The Children's Medical Center Corporation Inhibition of angiogenesis
IT1221734B (it) * 1983-02-24 1990-07-12 Schiena Michele Giuseppe Di Ursodesossicolico solfato acido sale sodico
US4545938A (en) * 1983-11-02 1985-10-08 Beth Israel Medical Center Chemical synthesis
WO1987002367A2 (fr) 1985-10-18 1987-04-23 The Upjohn Company Hydrocarbures cycliques avec chaine laterale aminoalkyle
US4771042A (en) * 1985-11-25 1988-09-13 The Upjohn Company Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
JPS62175497A (ja) * 1986-01-28 1987-08-01 Wakunaga Pharmaceut Co Ltd 胆汁酸誘導体およびその製造法
US5075464A (en) * 1987-04-22 1991-12-24 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropylamino)androstene derivatives
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US5135919A (en) * 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
IT1229570B (it) * 1989-04-17 1991-09-04 Giuliani Spa Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT1229569B (it) * 1989-04-17 1991-09-04 Giuliani Spa Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
JPH07116215B2 (ja) * 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
PT93847A (pt) 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
US4966897A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5004737A (en) * 1989-09-22 1991-04-02 Pacific Chemical Co., Ltd. Quaternary ammonium-substituted sterol derivatives
EP0466315A3 (en) 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
CA2081205C (fr) 1990-06-11 2001-02-27 John W. Wilks Steroides inhibant l'angiogenese
EP0489423B1 (fr) * 1990-12-06 1996-11-06 Hoechst Aktiengesellschaft Acides-billiaires, un procédé pour leur préparation et leur utilisation comme médicaments
US5192756A (en) * 1992-03-18 1993-03-09 The Children's Hospital Of Pennsylvania Aminosterol antibiotic
WO1993025197A1 (fr) 1992-06-12 1993-12-23 Affymax Technologies N.V. Compositions et procedes destines a ameliorer la liberation et l'acheminement de medicaments
US5247104A (en) * 1992-11-04 1993-09-21 Wisconsin Alumni Research Foundation Preparation of 1α, 24-dihydroxyvitamin D analogs
JPH06329679A (ja) 1993-01-20 1994-11-29 Nissan Chem Ind Ltd 光学活性β−アミノアルコキシボラン錯体
AU6392894A (en) 1993-02-26 1994-09-14 Magainin Pharmaceuticals, Inc. Chemical synthesis of squalamine
JP3546886B2 (ja) * 1993-03-10 2004-07-28 ジェネーラ コーポレーション ステロイド誘導体、それらを含む薬剤組成物、及び抗生物質又は消毒薬としてのそれらの使用
WO1994024800A1 (fr) 1993-04-12 1994-10-27 Unisys Corporation Adaptateur portable pour ordinateur personnel portable
DE69429364T2 (de) 1994-03-10 2002-08-08 Magainin Pharmaceuticals,Inc. Verwendung von steroidderivaten als arzneimittel
JP4104164B2 (ja) 1995-06-07 2008-06-18 ジェネーラ コーポレーション ナトリウム／プロトン交換体（ｎｈｅ）の阻害剤として有用なアミノステロール化合物、同阻害剤を使用する薬学的方法および組成物、ならびに化合物のｎｈｅ阻害効果を評価する方法
US5792635A (en) 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US6262283B1 (en) * 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds

Also Published As

Publication number Publication date
EP1274718A1 (fr) 2003-01-15
PT1274718E (pt) 2007-01-31
ATE342912T1 (de) 2006-11-15
AU2001253427B2 (en) 2007-02-08
JP2003531148A (ja) 2003-10-21
CA2406847A1 (fr) 2001-10-25
US20030171576A1 (en) 2003-09-11
DE60123939D1 (de) 2006-11-30
DE60123939T2 (de) 2007-05-31
CY1105870T1 (el) 2011-02-02
US7728157B2 (en) 2010-06-01
US20050187202A1 (en) 2005-08-25
ES2273831T3 (es) 2007-05-16
EP1274718B1 (fr) 2006-10-18
AU5342701A (en) 2001-10-30
US6933383B2 (en) 2005-08-23
WO2001079255A1 (fr) 2001-10-25
CA2406847C (fr) 2009-11-17

Similar Documents

Publication Publication Date Title
DK1274718T3 (da) En fremgangsmåde til forberedelse af 7.alpha.-hydroxy 3-aminosubstituerede steroler vee en ubeskyttet 7.alpha.-hydroxy gruppe
BR9714510A (pt) Processo e preparo de esteróides de 9,11-époxi e intermediários úteis dos mesmos
BR9509665A (pt) Composto composições e métodos
DK1608671T3 (da) Østrogenderivater som inhibitorer af steroidsulfatase
PT1053240E (pt) Agentes anti-inflamatorios selectivos para glucocorticoides
DK0856697T3 (da) Fremgangsmåde til foring af rør
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
DK1051177T3 (da) Steroide 3-O-Sulfamatderivater som inhibitorer af östronsulfatase
CO5251441A1 (es) Compuestos esteroides que contienen un anillo de ciclopropano
NO20023276L (no) Fremgangsmåter fremstilling av betulinsyre
NO20001510L (no) Spesifikke immunofilin-ligander som anti-asmatiske, anti- allergiske, anti-reumatiske, immunsuppressive, antipsoriatiske og neuroprotektive midler
HUP0500025A2 (hu) Tisztított lasofoxifene és eljárás racém lasofoxifene tisztítására átkristályosítással
DK0708762T3 (da) Fremgangsmåde til fremstilling af HIV protease-inhibitorer
NO20004664D0 (no) FremgangsmÕte for fremstilling av HIV proteaseinhibitorer
DK1163258T3 (da) Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis
DE59712632D1 (de) Verfahren zur herstellung von 3-pyrrolin-2-carbonsäure-derivaten
DK1343808T3 (da) Fremgangsmåde til syntese af et LHRA-peptid
HK1061860A1 (en) 17 Alpha fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds
DK1335928T3 (da) Selektive glukokortikoidreceptoragonister
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider
DK1019521T3 (da) Fremgangsmåde til biotransformation af colchiconforbindelser til de tilsvarende 3-glycosylderivater
MXPA03000845A (es) Estrogenos substituidos por 16alfa-metilo o etilo.
DK82491D0 (da) Fremgangsmaade til udgravningsfri erstatning af roerledninger
DK1080076T3 (da) Forbedret fremgangsmåde til fremstilling af farmaceutisk værdifulde norbenzomorphanderivater